Thousands of bottles of a commonly prescribed blood pressure medication are being recalled across the United States, according to a recent announcement from the U.S. Food and Drug Administration (FDA).
Inventia Healthcare Limited has voluntarily recalled certain lots of Chlorthalidone Tablets after the medication failed to meet dissolution specifications. The FDA announced the recall on June 5.
According to the agency, more than 11,400 bottles are affected by the recall. The recalled products carry an expiration date of April 2027.
What Is Chlorthalidone?
Chlorthalidone is a prescription medication commonly used to treat high blood pressure (hypertension). According to the Mayo Clinic, it may also be prescribed to help reduce fluid retention associated with certain medical conditions.
Doctors often prescribe the medication either on its own or in combination with other treatments to help lower blood pressure and reduce the risk of complications associated with hypertension.
Why Was the Medication Recalled?
The FDA said the recall was initiated because the affected tablets failed dissolution specifications.
Dissolution testing helps determine whether a medication dissolves properly in the body after being taken. When a drug does not dissolve as expected, it may affect how well the medication works or how much of the active ingredient becomes available for absorption.
The recall was voluntary and initiated by the manufacturer.
Recalled Product Information
The recall includes:
- Chlorthalidone Tablets, USP, 25 mg
- Bottle sizes: 100-count and 1,000-count
Patients who currently take Chlorthalidone should not stop taking their medication without first speaking with their healthcare provider.
Another Recent Blood Pressure Drug Recall
The Chlorthalidone recall follows another major blood pressure medication recall announced in October.
At that time, more than 500,000 bottles of Prazosin Hydrochloride were recalled after concerns that certain lots contained elevated levels of a potentially cancer-causing impurity. Patients were advised to contact their pharmacist or healthcare provider if they believed they had received the affected product.
What Should Patients Do?
Anyone taking Chlorthalidone who is concerned about the recall should check their prescription information and contact their pharmacist or healthcare provider for guidance.
Patients should never discontinue a prescribed blood pressure medication without medical supervision, as doing so could increase the risk of serious health complications.
As always, consumers can visit the FDA’s website for the latest recall information and updates.
